infiniwell bpc-157 rapid 250mcg product information Original 60c BPC-157 Dosage Protocol: Injection Guide
Description
In September 2023, the FDA classified BPC-157 as a Category 2 compound under the 503A bulking list, restricting its use by American compounding pharmacies
By combining Sermorelin and GHRP-2 Blend protocols in a single vial, researchers can observe how these two distinct pathways interact
The codes are updated at regular intervals to keep up with medical and technological advancements
Doses over 150 mcg are most effective
